Long-Term Follow-Up of Patients Needing Extracorporeal Membrane Oxygenation Following a Critical Course of COVID-19.
COVID-19
ECMO
long-term outcome
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
20 Apr 2023
20 Apr 2023
Historique:
received:
21
03
2023
revised:
14
04
2023
accepted:
17
04
2023
medline:
28
4
2023
pubmed:
28
4
2023
entrez:
28
4
2023
Statut:
epublish
Résumé
Severe respiratory failure is one of the most serious complications of coronavirus disease 2019 (COVID-19). In a small proportion of patients, mechanical ventilation fails to provide adequate oxygenation and extracorporeal membrane oxygenation (ECMO) is needed. The surviving individuals need long-term follow-up as it is not clear what their prognosis is. To provide a complex clinical picture of patients during follow-up exceeding one year after the ECMO therapy due to severe COVID-19. All subjects involved in the study required ECMO in the acute stage of COVID-19. The survivors were followed-up for over one year at a specialized respiratory medical center. Of the 41 patients indicated for ECMO, 17 patients (64.7% males) survived. The average age of survivors was 47.8 years, and the average BMI was 34.7 kg·m The COVID-19 pandemic has significantly increased the need for ECMO. Patients' quality of life after ECMO is temporarily significantly reduced but most patients do not experience permanent disability.
Identifiants
pubmed: 37109583
pii: life13041054
doi: 10.3390/life13041054
pmc: PMC10143867
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Acute Crit Care. 2022 Feb;37(1):26-34
pubmed: 35279976
Respir Med. 2022 Jan;191:106709
pubmed: 34871947
Crit Care Med. 2020 Oct;48(10):e959-e970
pubmed: 32886470
Intensive Care Med. 2022 Oct;48(10):1326-1337
pubmed: 35945343
J Clin Med. 2022 May 24;11(11):
pubmed: 35683340
ERJ Open Res. 2021 Aug 23;7(3):
pubmed: 34435038
Eur J Clin Invest. 2022 Oct;52(10):e13845
pubmed: 35904405
Eur Radiol. 2001;11(12):2436-43
pubmed: 11734936
Clin Microbiol Infect. 2021 Dec;27 Suppl 2:S1-S21
pubmed: 34678515
Crit Care. 2014 Jan 21;18(1):203
pubmed: 24447458
Life (Basel). 2023 Mar 02;13(3):
pubmed: 36983838
Clin Infect Dis. 2022 Apr 9;74(7):1191-1198
pubmed: 34223884
N Engl J Med. 2018 May 24;378(21):1965-1975
pubmed: 29791822
Crit Care Explor. 2021 Jul 16;3(7):e0494
pubmed: 34291224
Anesthesiology. 2019 Apr;130(4):572-580
pubmed: 30875355
J Community Hosp Intern Med Perspect. 2021 Nov 15;11(6):733-739
pubmed: 34804382
J Intensive Care Med. 2011 Jan-Feb;26(1):13-26
pubmed: 21262750
EClinicalMedicine. 2021 Jan 07;31:100683
pubmed: 33490928
Lancet Reg Health Am. 2021 Dec;4:100065
pubmed: 34522911
Psychosomatics. 2013 Sep-Oct;54(5):418-27
pubmed: 23756125
Perfusion. 2023 Mar;38(2):236-244
pubmed: 34961381
BMC Infect Dis. 2022 Sep 19;22(1):742
pubmed: 36123623
Chest. 2003 Mar;123(3):845-53
pubmed: 12628887
Infection. 2022 Apr;50(2):447-456
pubmed: 34668145
Acta Anaesthesiol Scand. 2009 Apr;53(4):489-95
pubmed: 19226296
Front Med (Lausanne). 2022 Jul 14;9:897990
pubmed: 35911414
J Sleep Res. 2022 Apr;31(2):e13454
pubmed: 34350639
Am J Physiol Cell Physiol. 2022 Jan 1;322(1):C1-C11
pubmed: 34817268
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Sep 6;:
pubmed: 36128850
Vaccines (Basel). 2021 Sep 24;9(10):
pubmed: 34696179
J Thorac Dis. 2015 Jul;7(7):E166-76
pubmed: 26380745
Life (Basel). 2022 Mar 31;12(4):
pubmed: 35455008
Cochrane Database Syst Rev. 2022 Nov 17;11:CD013652
pubmed: 36394900
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151
Eur Respir J Suppl. 2003 Aug;42:2s-9s
pubmed: 12945994
JAMA. 2022 Nov 8;328(18):1827-1836
pubmed: 36286084